COM:ARCTURUSRX
Arcturus Therapeutics
- Stock
Last Close
17.07
22/11 21:00
Market Cap
585.23M
Beta: -
Volume Today
512.97K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -23K - | -23K 0% | -58K 152.17% | -318.50K 449.14% | 469.50K 247.41% | 730K 55.48% | ||||||
average payables | 35K - | 176K 402.86% | 181K 2.84% | 292.50K 61.60% | 1.16M 296.24% | 2.09M 80.67% | 4.10M 95.58% | 8.28M 102.26% | 10.42M 25.74% | 8.75M 15.96% | 6.36M 27.30% | |
average receivables | 28K - | 81.50K 191.07% | 116.50K 42.94% | 318.50K 173.39% | 500.50K 57.14% | 2.48M 395.60% | 3.33M 34.25% | 2.15M 35.38% | 2.75M 27.60% | 3.07M 11.64% | 17.41M 468.06% | |
book value per share | 33.49 - | 10.21 69.51% | 22.43 119.70% | 11.99 46.52% | 10.95 8.73% | 1.35 87.62% | 2.14 57.73% | 19.53 813.87% | 8.67 55.60% | 10.22 17.87% | 10.58 3.48% | |
capex per share | -0.03 - | -0.04 50.76% | -0.06 44.79% | -0.02 67.90% | -0.08 332.64% | -0.15 80.53% | -0.07 53.83% | -0.09 26.58% | -0.13 50.86% | -0.29 125.74% | ||
capex to depreciation | -4.88 - | -2.55 47.73% | -3.55 39.27% | -1.21 65.82% | -0.61 49.54% | -2.54 314.82% | -1.20 52.91% | -1.98 65.15% | -2.85 44.55% | -5.06 77.22% | ||
capex to operating cash flow | 0.01 - | 0.00 47.42% | 0.01 257.61% | 0.00 61.44% | 0.55 14,087.69% | 0.07 86.95% | 0.13 78.27% | 0.04 67.98% | 0.03 37.94% | -0.24 1,057.47% | ||
capex to revenue | -0.02 - | -0.09 385.86% | -0.04 58.06% | -0.18 364.11% | -0.28 50.91% | -0.04 86.37% | ||||||
cash per share | 34.46 - | 11.11 67.77% | 16.40 47.61% | 12.76 22.17% | 15.73 23.31% | 3.65 76.83% | 5.91 62.16% | 22.80 285.60% | 14.08 38.25% | 14.82 5.26% | 13.03 12.06% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 13.48 - | 103.83 670.28% | 38.26 63.15% | 81.31 112.54% | 99.44 22.29% | 4.90 95.07% | 68.87 1,304.60% | |||||
debt to assets | 0.22 - | 0.25 12.23% | 0.04 82.69% | 0.17 295.20% | 0.20 17.23% | 0.00 100.00% | ||||||
debt to equity | 0.73 - | 0.80 10.32% | 0.05 93.47% | 0.30 466.18% | 0.34 13.47% | 0.00 100.00% | ||||||
dividend yield | ||||||||||||
earnings yield | -0.06 - | -0.64 1,018.02% | -0.14 77.77% | -0.43 196.98% | -0.44 3.99% | -0.48 8.06% | -0.20 58.95% | -0.08 58.68% | -0.21 162.14% | 0.02 109.81% | -0.03 251.94% | |
enterprise value | 161.10M - | 48.83M 69.69% | 119.23M 144.17% | 55.71M 53.27% | -299.87K 100.54% | 18.81M 6,374.24% | 79.68M 323.51% | 435.81M 446.93% | 671.11M 53.99% | 147.50M 78.02% | 518.48M 251.53% | |
enterprise value over ebitda | -15.67 - | -1.49 90.50% | -6.07 307.85% | -2.22 63.43% | 0.03 101.31% | -0.90 3,187.12% | -3.12 248.44% | -6.07 94.62% | -3.35 44.83% | 12.65 477.65% | -6.91 154.61% | |
ev to operating cash flow | -21.91 - | -1.72 92.13% | -6.57 281.11% | -2.90 55.93% | 0.65 122.51% | -0.91 239.02% | -12.36 1,264.18% | -10.17 17.76% | -4.97 51.12% | 4.61 192.77% | ||
ev to sales | -0.02 - | 1.19 5,276.96% | 3.83 220.92% | 45.69 1,091.96% | 54.30 18.86% | 0.72 98.68% | 3.05 325.63% | |||||
free cash flow per share | -5.08 - | -14.54 186.00% | -5.93 59.22% | -4.91 17.27% | -0.23 95.30% | -2.21 858.91% | -0.60 72.75% | -2.20 265.02% | -5.26 139.49% | 0.92 117.44% | ||
free cash flow yield | -0.04 - | -0.56 1,280.16% | -0.13 75.78% | -0.33 147.40% | -0.03 91.36% | -0.49 1,591.32% | -0.06 88.64% | -0.05 8.53% | -0.14 180.71% | 0.05 138.06% | ||
graham net net | 33.34 - | 9.94 70.20% | 15.64 57.44% | 11.69 25.27% | 10.18 12.90% | 0.94 90.72% | 1.38 45.89% | 18.94 1,274.06% | 7.92 58.19% | 8.09 2.13% | 8.39 3.69% | |
graham number | 73.93 - | 62.13 15.96% | 56.35 9.31% | 41.06 27.12% | 29.49 28.18% | 8.12 72.46% | 10.12 24.65% | 39.30 288.21% | 39.16 0.35% | 9.02 76.98% | 15.42 70.97% | |
income quality | 0.70 - | 0.86 23.76% | 0.93 8.16% | 0.78 16.19% | 0.04 94.60% | 0.95 2,158.49% | 0.25 73.98% | 0.59 139.57% | 0.66 11.61% | 3.42 416.12% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -52.23 - | -16.54K 31,563.59% | 65.66 100.40% | 39.51 39.83% | -69.95 277.04% | -117.26 67.65% | -57.20 51.22% | -198.13 246.35% | -75.86 61.71% | 28.99 138.22% | ||
interest debt per share | 0.14 - | 0.00 99.24% | -0.10 9,579.63% | -0.16 66.69% | 0.05 130.04% | 1.00 1,963.72% | 1.75 74.49% | 1.04 40.58% | 2.67 156.87% | 3.45 29.26% | 0.00 100.00% | |
inventory turnover | ||||||||||||
invested capital | 0.73 - | 0.80 10.32% | 0.05 93.47% | 0.30 466.18% | 0.34 13.47% | 0.00 100.00% | ||||||
market cap | 183.20M - | 51.01M 72.16% | 135.89M 166.41% | 57.88M 57.40% | 24.67M 57.39% | 45.61M 84.93% | 131.19M 187.62% | 880.83M 571.42% | 973.99M 10.58% | 448.51M 53.95% | 839.58M 87.19% | |
net current asset value | 48.58M - | 19.75M 59.35% | 49.99M 153.12% | 46.96M 6.07% | 32.64M 30.50% | 11.27M 65.46% | 17.94M 59.15% | 387.89M 2,062.25% | 214.36M 44.74% | 223.26M 4.15% | 238.84M 6.98% | |
net debt to ebitda | 2.15 - | 0.07 96.91% | 0.85 1,178.73% | 0.09 89.80% | 2.41 2,691.82% | 1.28 47.18% | 2.02 58.14% | 6.20 207.45% | 1.51 75.62% | -25.81 1,807.71% | 4.28 116.57% | |
net income per share | -7.25 - | -16.81 131.68% | -6.29 62.57% | -6.25 0.69% | -3.53 43.48% | -2.16 38.74% | -2.13 1.50% | -3.51 64.91% | -7.86 123.65% | 0.35 104.50% | -1.00 382.47% | |
operating cash flow per share | -5.06 - | -14.50 186.72% | -5.87 59.51% | -4.89 16.77% | -0.15 96.95% | -2.06 1,283.63% | -0.53 74.10% | -2.11 295.28% | -5.13 143.10% | 1.21 123.58% | ||
payables turnover | ||||||||||||
receivables turnover | 27.08 - | 3.52 87.02% | 9.54 171.39% | 4.49 52.95% | 3.67 18.23% | 74.44 1,928.02% | 5.30 92.88% | |||||
research and ddevelopement to revenue | 1.22 - | 1.08 11.97% | 1.62 50.11% | 6.06 274.76% | 14.06 131.84% | 0.72 94.89% | 1.13 57.45% | |||||
return on tangible assets | -0.21 - | -1.47 601.90% | -0.27 81.56% | -0.48 75.84% | -0.21 56.08% | -0.49 135.21% | -0.31 36.47% | -0.15 52.17% | -0.53 251.59% | 0.02 103.94% | -0.06 398.33% | |
revenue per share | 4.21 - | 1.56 62.84% | 1.72 10.10% | 0.47 72.73% | 0.47 0.04% | 7.78 1,556.76% | 6.38 17.98% | |||||
roe | -0.22 - | -1.65 659.95% | -0.28 82.96% | -0.52 85.70% | -0.32 38.07% | -1.60 395.01% | -1.00 37.55% | -0.18 81.95% | -0.91 403.70% | 0.03 103.82% | -0.09 372.98% | |
roic | -0.21 - | -1.66 679.85% | -0.28 82.82% | -0.53 87.62% | -0.31 41.91% | -0.94 201.15% | -0.49 47.38% | -0.17 65.87% | -0.69 308.56% | 0.03 103.98% | -0.26 1,059.45% | |
sales general and administrative to revenue | 0.58 - | 1.31 124.28% | 0.61 53.38% | 2.43 299.61% | 3.35 37.80% | 0.22 93.32% | ||||||
shareholders equity per share | 33.49 - | 10.21 69.51% | 22.43 119.70% | 11.99 46.52% | 10.95 8.73% | 1.35 87.62% | 2.14 57.73% | 19.53 813.87% | 8.67 55.60% | 10.22 17.87% | 10.58 3.48% | |
stock based compensation to revenue | 0.17 - | 0.08 52.13% | 0.10 19.29% | 0.71 643.76% | 2.34 229.94% | 0.15 93.64% | ||||||
tangible asset value | 48.69M - | 19.94M 59.04% | 69.33M 247.65% | 47.23M 31.88% | 33.79M 28.44% | 13.64M 59.63% | 25.79M 89.06% | 396.55M 1,437.50% | 228.21M 42.45% | 270.31M 18.45% | 281.65M 4.19% | |
tangible book value per share | 33.49 - | 10.21 69.51% | 22.43 119.70% | 11.99 46.52% | 10.95 8.73% | 1.35 87.62% | 2.14 57.73% | 19.53 813.87% | 8.67 55.60% | 10.22 17.87% | 10.58 3.48% | |
working capital | 48.58M - | 19.75M 59.35% | 49.99M 153.12% | 46.96M 6.07% | 39.83M 15.19% | 29.25M 26.56% | 52.97M 81.07% | 418.27M 689.69% | 279.42M 33.19% | 276.35M 1.10% | 307.74M 11.36% |
All numbers in (except ratios and percentages)